Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Envoy Medical Inc (COCH)

Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 33,404
  • Shares Outstanding, K 20,245
  • Annual Sales, $ 320 K
  • Annual Income, $ -29,910 K
  • EBIT $ -27 M
  • EBITDA $ -27 M
  • 60-Month Beta 2.23
  • Price/Sales 117.88
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.33
  • Number of Estimates 3
  • High Estimate -0.25
  • Low Estimate -0.39
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5900 +3.77%
on 12/19/24
2.3200 -28.88%
on 12/02/24
-0.5000 (-23.26%)
since 11/20/24
3-Month
1.5900 +3.77%
on 12/19/24
3.9900 -58.65%
on 09/23/24
-1.8500 (-52.86%)
since 09/20/24
52-Week
1.0800 +52.78%
on 01/30/24
11.4600 -85.60%
on 03/07/24
-0.6000 (-26.67%)
since 12/20/23

Most Recent Stories

More News
Envoy Medical Names Seven Investigational Sites for Participation in Its Pivotal Clinical Study

Initial patient enrollment anticipated during first quarter of 2025White Bear Lake, Minnesota--(Newsfile Corp. - December 19, 2024) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health...

COCH : 1.6500 (-10.33%)
Envoy Medical, Inc. Announces Issuance of Four New Patents for Innovative Cochlear Implant Technologies

Envoy Medical announces four new patents related to cochlear implants and hearing aids, enhancing innovative hearing solutions.Quiver AI SummaryEnvoy Medical, Inc. announced the issuance of four new patents...

COCH : 1.6500 (-10.33%)
Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

COCH : 1.6500 (-10.33%)
Envoy Medical Reports Q3 2024 Financial Results and Progress on Fully Implanted Hearing Devices

Envoy Medical reports Q3 2024 results, highlighting FDA approval for Acclaim CI trial and reimbursement progress for Esteem device.Quiver AI SummaryEnvoy Medical, Inc. reported its third-quarter financial...

COCH : 1.6500 (-10.33%)
Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

COCH : 1.6500 (-10.33%)
Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

COCH : 1.6500 (-10.33%)
Building Permits, Vehicle Sales Due Next Week

Monday U.S. Featured Earnings Monday.Com Ltd (NASDAQ: MNDY) (Q3) EPS of four cents, compared ...

BABA : 82.28 (-2.41%)
HAFN : 5.11 (+0.20%)
AMAT : 163.59 (+1.33%)
CSCO : 58.52 (+1.54%)
NVA.TO : 12.33 (+0.57%)
NU : 10.38 (+0.48%)
BN : 56.09 (+1.08%)
COCH : 1.6500 (-10.33%)
DIS : 112.03 (+0.59%)
SHOP : 108.95 (+1.76%)
ARMK : 37.62 (+0.56%)
ZETA : 19.40 (+1.73%)
Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

COCH : 1.6500 (-10.33%)
Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

COCH : 1.6500 (-10.33%)
Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

COCH : 1.6500 (-10.33%)

Business Summary

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

See More

Key Turning Points

3rd Resistance Point 2.2467
2nd Resistance Point 2.1233
1st Resistance Point 1.8867
Last Price 1.6500
1st Support Level 1.5267
2nd Support Level 1.4033
3rd Support Level 1.1667

See More

52-Week High 11.4600
Fibonacci 61.8% 7.4948
Fibonacci 50% 6.2700
Fibonacci 38.2% 5.0452
Last Price 1.6500
52-Week Low 1.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar